NCT05677490 · Interventional trial
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Overall registry status Recruiting
Phase 3
Conditions Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Metastatic Esophageal Adenocarcinoma, Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Unresectable Esophageal Adenocarcinoma, Unresectable Gastric Adenocarcinoma, Unresectable Gastroesophageal Junction Adenocarcinoma
Delaware Valley sites
- Asplundh Cancer Pavilion · Willow Grove, PA · Montgomery County · Active not recruiting
- Einstein Medical Center Philadelphia · Philadelphia, PA · Philadelphia County · Active not recruiting
- Jefferson Cherry Hill Hospital · Cherry Hill, NJ · Camden County · Active not recruiting
- Sidney Kimmel Cancer Center Washington Township · Sewell, NJ · Gloucester County · Active not recruiting
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County · Active not recruiting
First posted
Registry updated
Added to the directory